Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
INTERCEPT PHARMACEUTICALS, INC. | Chief Accounting Officer | Common Stock | 0 | $19.00 | Nov 8, 2023 | Direct | |
INTERCEPT PHARMACEUTICALS, INC. | Chief Accounting Officer | Option to Purchase Common Stock | 0 | Nov 8, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ICPT | INTERCEPT PHARMACEUTICALS, INC. | Nov 8, 2023 | 14 | -$484K | 4 | Nov 13, 2023 | Chief Accounting Officer |
ICPT | INTERCEPT PHARMACEUTICALS, INC. | Jan 27, 2023 | 2 | $0 | 4 | Jan 31, 2023 | Chief Accounting Officer |
ICPT | INTERCEPT PHARMACEUTICALS, INC. | Dec 31, 2022 | 1 | -$8.35K | 4 | Jan 3, 2023 | Chief Accounting Officer |
ICPT | INTERCEPT PHARMACEUTICALS, INC. | Sep 1, 2022 | 1 | -$7.75K | 4 | Sep 6, 2022 | Chief Accounting Officer |
ICPT | INTERCEPT PHARMACEUTICALS, INC. | Jan 27, 2022 | 2 | $0 | 4 | Jan 31, 2022 | Chief Accounting Officer |
ICPT | INTERCEPT PHARMACEUTICALS, INC. | Dec 31, 2021 | 2 | -$8.96K | 4 | Jan 4, 2022 | Chief Accounting Officer |
ICPT | INTERCEPT PHARMACEUTICALS, INC. | Oct 1, 2021 | 1 | -$457 | 4 | Oct 5, 2021 | Chief Accounting Officer |
ICPT | INTERCEPT PHARMACEUTICALS, INC. | Sep 1, 2021 | 1 | -$7.89K | 4 | Sep 3, 2021 | Chief Accounting Officer |
ICPT | INTERCEPT PHARMACEUTICALS, INC. | Jul 1, 2021 | 1 | -$614 | 4 | Jul 2, 2021 | Chief Accounting Officer |